These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27079348)

  • 21. Discover diabetes: screening for diabetes mellitus in the Waikato.
    Lawrenson RA; Dunn PJ; Jury D; Sceats J
    N Z Med J; 1993 Dec; 106(969):522-4. PubMed ID: 8183493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus.
    Kim C; Herman WH; Vijan S
    Diabetes Care; 2007 May; 30(5):1102-6. PubMed ID: 17322480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The health system and population health implications of large-scale diabetes screening in India: a microsimulation model of alternative approaches.
    Basu S; Millett C; Vijan S; Hayward RA; Kinra S; Ahuja R; Yudkin JS
    PLoS Med; 2015 May; 12(5):e1001827; discussion e1001827. PubMed ID: 25992895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycosuric tests should not be employed in population screenings for NIDDM.
    Friderichsen B; Maunsbach M
    J Public Health Med; 1997 Mar; 19(1):55-60. PubMed ID: 9138218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the evidence support population-wide screening for type 2 diabetes? No.
    Shaw JE
    Diabetologia; 2017 Nov; 60(11):2153-2156. PubMed ID: 28831520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of surveillance-based metrics for the assessment and monitoring of disease detection: simulation study about type 2 diabetes.
    Brinks R; Hoyer A; Rolka DB; Kuss O; Gregg EW
    BMC Med Res Methodol; 2017 Apr; 17(1):54. PubMed ID: 28399821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening for type 2 diabetes mellitus: more than looking for undiagnosed diabetes].
    González-Clemente JM
    Med Clin (Barc); 2004 Jul; 123(5):177-80. PubMed ID: 15274796
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnosing the undiagnosed with diabetes.
    Home PD
    BMJ; 1994 Mar; 308(6929):611-2. PubMed ID: 8148705
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurological disorder screening in the elderly in low-income countries.
    Dewhurst F; Dewhurst MJ; Orega G; Gray WK; Howlett W; Warren N; Aris E; Walker RW
    J Neurol; 2012 Oct; 259(10):2189-97. PubMed ID: 22527223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Indian Diabetes Risk Score and Random Blood Sugar Testing for Opportunistic Screening of Type 2 Diabetes Patients at a District Hospital of Gujarat.
    Fichadiya NC; Kadri AM; Dave BB
    Indian J Community Med; 2022; 47(4):517-521. PubMed ID: 36742959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonlaboratory-Based Risk Assessment Model For Type 2 Diabetes Mellitus Screening in Chinese Rural Population: A Joint Bagging-Boosting Model.
    Zhang L; Wang Y; Niu M; Wang C; Wang Z
    IEEE J Biomed Health Inform; 2021 Oct; 25(10):4005-4016. PubMed ID: 33939617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Screening Strategies for Diabetes Mellitus by Leveraging Dental Visits Using Optimal Screening Tools Available Onsite.
    Mirza W; Saleem MS; Patel G; Chacko P; Reddy S; Schaefer R; Jones R; Dheer N; Dharampuri S; Sandhu A
    Cureus; 2018 Nov; 10(11):e3641. PubMed ID: 30723641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MINERAL WATER "DZUGURI" AND TYPE 2 DIABETES MELLITUS: SCREENING RESULTS.
    Gabritchidze S; Karanadze N; Charkviani N; Chokhonelidze A
    Georgian Med News; 2021 May; (314):121-124. PubMed ID: 34248040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Algorithm to Improve Patient Comfort and Treat Diabetes Mellitus-Related Xerosis.
    Kirsner R; Andriessen A; Hanft J; Hu S; Ruotsi L; Yosipovitch G
    J Drugs Dermatol; 2023 Apr; 22(4):356-363. PubMed ID: 37026891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opportunistic screening for diabetes.
    Easton JL; Segal L
    Med J Aust; 1998 Jan; 168(1):45. PubMed ID: 9451399
    [No Abstract]   [Full Text] [Related]  

  • 36. Developing a Screening Algorithm for Type II Diabetes Mellitus in the Resource-Limited Setting of Rural Tanzania.
    West C; Ploth D; Fonner V; Mbwambo J; Fredrick F; Sweat M
    Am J Med Sci; 2016 Apr; 351(4):408-15. PubMed ID: 27079348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple non-laboratory- and laboratory-based risk assessment algorithms and nomogram for detecting undiagnosed diabetes mellitus.
    Wong CK; Siu SC; Wan EY; Jiao FF; Yu EY; Fung CS; Wong KW; Leung AY; Lam CL
    J Diabetes; 2016 May; 8(3):414-21. PubMed ID: 25952330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postpartum diabetes screening in women with a history of gestational diabetes.
    Smirnakis KV; Chasan-Taber L; Wolf M; Markenson G; Ecker JL; Thadhani R
    Obstet Gynecol; 2005 Dec; 106(6):1297-303. PubMed ID: 16319255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why screening for type 2 diabetes is necessary even in poor resource settings.
    Unnikrishnan R; Mohan V
    J Diabetes Complications; 2015; 29(7):961-4. PubMed ID: 26099834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection.
    Largen A; Ayala A; Khurana R; Katz DJ; Venkatappa TK; Brostrom R
    Int J Tuberc Lung Dis; 2021 Jul; 25(7):547-553. PubMed ID: 34183099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.